Administration of ATCC14019 vaginally into pregnant mice resulted in evidence of cervical remodeling and increased IL-6 in the vagina and amniotic fluid (Sierra et al., 2018), consistent with findings of elevated IL-6 in women with BV (Yudin et al., 2003; Campos et al., 2012) and associations of clade1/2 G. This evidence concerns the gene IL6 and bacterial vaginosis.